When compared to white women, African American women are less likely to be diagnosed by breast cancer, but more likely to die from it. Moreover, decreases in national rates of breast cancer-related mortality have historically been seen in white populations years before African American ones. CHAS Fellow Olufunmilayo Olopade and Bobby Daly of Memorial Sloan Kettering Cancer Center thus explore the racial disparities in breast cancer treatment while they also highlight effective interventions and areas for further research. The paper indicates that previous attempts to close the gap focused too narrowly on the patient rather than systematic failures in care.